Pediatric Multisystem Inflammatory Disease and COVID-19

July 24, 2020


Until more is known about long-term cardiac mechanisms behind MIS-C, providers could consider following Kawasaki disease guidelines for follow-up care

FDA Clears Blood Test to Identify Red Meat Sensitization

July 23, 2020


It has been notoriously difficult to measure sensitization to the alpha-Gal carbohydrate.

AR101 Leads to Rapid Desensitization of Peanut Protein

July 22, 2020


The findings provide data to help physicians, patients, and caregivers make informed, shared decisions on the management of peanut allergy.

Barriers Prevent Pediatricians from Implementing Peanut Allergy Guidelines

July 15, 2020


Although a majority of pediatricians are aware of the guidelines, less than one-third of survey respondents report full implementation.

Epicutaneous Immunotherapy Effective for Peanut Allergy in Children

July 13, 2020


The results further support the overall benefit of epicutaneous immunotherapy.

Very Early Spring Onset Associated With Asthma-Related Hospital Admissions

July 07, 2020


There is also an association between late onset of spring and an increase in hospital admissions for asthma.

Dupilumab Hits Phase 3 Endpoints for Eosinophilic Esophagitis

May 27, 2020


The biologic has now shown significant efficacy in treating 4 different atopic or type 2 inflammatory diseases.

FDA Approves Dupilumab for Pediatric Eczema

May 26, 2020


The newest indication for the add-on biologic grants it use in children aged 6-11 years old with moderate to severe, uncontrolled atopic dermatitis.

The Role of Autoantibodies in Untreated Psychosis

April 27, 2020


A look at how the antibody influences the pathology of encephalitis, and how it can be properly assessed and treated.

Ixekizumab Continues to Build Chronic Care Portfolio

April 15, 2020


The IL-17A-targeting biologic has now been indicated for pediatric plaque psoriasis—marking its fourth indication for patients with chronic diseases.